Chongqing Pharscin Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 645.34 million compared to CNY 624.94 million a year ago. Revenue was CNY 645.34 million compared to CNY 624.94 million a year ago. Net income was CNY 89.44 million compared to CNY 94.78 million a year ago. Basic earnings per share from continuing operations was CNY 0.223 compared to CNY 0.2367 a year ago. Diluted earnings per share from continuing operations was CNY 0.223 compared to CNY 0.2367 a year ago.